Simulations Plus Inc (SLP)

Add to Watchlists
Create an Alert
Quickflows
46.92 +1.55  +3.42% NASDAQ Jul 28, 13:23 USD
View Full Chart
Price Chart
View All Key Stats

Key Stats

View All SLP News

News

View All Events

Events

Date Type Description
11/16/2021 Earnings Results Q4 2021 Earnings Results
11/16/2021 16:15 EST Earnings Calls Q4 2021 Earnings Call
07/23/2021 Dividends 0.06 Normal dividend, declared July 12, 2021 and paid August 02, 2021
07/12/2021 Earnings Results Q3 2021 Earnings Results
07/12/2021 16:15 EST Earnings Calls Q3 2021 Earnings Call
04/23/2021 Dividends 0.06 Normal dividend, declared April 12, 2021 and paid May 03, 2021
04/12/2021 Earnings Results Q2 2021 Earnings Results
04/12/2021 16:15 EST Earnings Calls Q2 2021 Earnings Call
02/25/2021 17:00 EST AGM 2020 Annual General Meeting
01/22/2021 Dividends 0.06 Normal dividend, declared January 12, 2021 and paid February 01, 2021
View All Performance Charts

Total Returns Comparison

Fundamentals

Income Statement View Statement

Revenue (TTM) 46.17M
Total Expenses (TTM) 32.88M
Net Income (TTM) 11.67M

Balance Sheet View Statement

Total Assets (Quarterly) 179.08M
Total Liabilities (Quarterly) 13.68M
Shareholders Equity (Quarterly) 165.40M

Cash Flow Statement View Statement

Cash from Operations (TTM) 15.74M
Cash from Investing (TTM) -67.13M
Cash from Financing (TTM) 102.85M

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Simulations Plus Inc is engaged in the software industry. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Simulations Plus, Inc; Cognigen Corporation; DILIsym, and Lixoft. It generates maximum revenue from Simulations Plus, Inc segment. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity) Predictor which is a computer program that takes molecular structures as inputs; MedChem Designer and MedChem Studio.
  • URL: https://www.simulations-plus.com
  • Investor Relations URL: https://www.simulations-plus.com/investorscorporate-profile/corporate-profile/
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Health Information Services
  • Equity Style: Small Cap/Growth
  • Next Earnings Release: Nov. 16, 2021
  • Last Earnings Release: Jul. 12, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: Jul. 23, 2021

Analyst Coverage

Consensus Recommendations
Buy Recommendations Upgrade
Outperform Recommendations Upgrade
Hold Recommendations Upgrade
Underperform Recommendations Upgrade
Sell Recommendations Upgrade
Consensus Recommendation Upgrade
Consensus Rating Upgrade
Target Price
Price 46.92
Price Target Upgrade
Price Target Upside (Daily) Upgrade

Top Fund Holders

Symbol Name Weighting
RFIMX Ranger Micro Cap Institutional 3.45%
PBSYX Polen US Small Company Growth Y 3.22%
RFISX Ranger Small Cap Institutional 2.49%
RTSGX Transamerica Small Cap Growth R6 2.13%
DTSGX Wilshire Small Company Growth Invmt 1.25%
RNSC First Trust Small Cap US Equity Sel ETF 0.76%
RSCRX Russell Inv US Small Cap Equity R6 0.54%

Comparables

Edit
INOV Inovalon Holdings Inc
ONEM 1Life Healthcare Inc
SDGR Schrodinger Inc
VEEV Veeva Systems Inc
VNTH Nano Mobile Healthcare Inc

Other Resources

Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.